帕金森病脑深部电刺激的居家健康管理:一项随机临床试验
这项开放标签随机临床试验在佛罗里达大学健康中心开展,纳入44例接受脑深部电刺激(DBS)的帕金森病患者,比较居家健康管理与标准术后管理6个月的效果。结果显示居家健康管理组运动障碍门诊就诊次数显著少于标准管理组(平均0.4次 vs 4.8次,P<.001),DBS疗效相关次要结局无显著差异,且未发生与研究操作或设备相关的不良事件。
要点
- 居家健康管理可显著减少帕金森病DBS术后患者往返门诊的次数。
- 两组在DBS疗效的次要结局上未见显著差异。
- 研究未观察到与研究操作或设备相关的不良事件。
核心结论
- 本研究为帕金森病DBS术后居家健康管理的安全性和可行性提供了证据。
研究设计与样本
- 开放标签随机临床试验,2017年11月至2020年4月在佛罗里达大学健康中心开展。
- 纳入诊断为帕金森病且计划接受DBS的患者,按1:1随机分配至标准术后管理或居家健康管理,干预持续术后6个月。
- 共44例患者入组,最终分析纳入标准管理组19例(平均年龄64.1岁,11名男性)和居家健康管理组23例(平均年龄65.0岁,13名男性)。
- 主要 caregivers(通常为配偶)也纳入研究以评估照护者负担。
主要发现
- 居家健康管理组患者运动障碍门诊就诊次数显著少于标准管理组(平均0.4次 vs 4.8次,P<.001)。
- 两组在统一帕金森病评定量表第三部分(UPDRS part III)等DBS疗效次要结局上无显著差异。
- 未发生与研究操作或设备相关的不良事件。
关键数值与推荐
- 主要结局为研究期间每例患者前往运动障碍门诊的次数。
- 次要结局包括统一帕金森病评定量表第三部分(UPDRS part III)较基线的变化。
临床怎么用
- 对于帕金森病DBS术后患者,可考虑采用由居家健康护士借助iPad版移动应用程序进行DBS参数调整的居家管理模式。
- 该模式有助于减少患者往返门诊的负担,且在本研究中未显示疗效劣于标准管理。
局限性
- 研究为开放标签设计,未设盲。
- 样本量较小,共44例患者纳入分析。
- 研究在单一中心开展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The travel required to receive deep brain stimulation (DBS) programming causes substantial burden on patients and limits who can access DBS therapy. OBJECTIVE: To evaluate the efficacy of home health DBS postoperative management in an effort to reduce travel burden and improve access. DESIGN, SETTINGS, AND PARTICIPANTS: This open-label randomized clinical trial was conducted at University of Florida Health from November 2017 to April 2020. Eligible participants had a diagnosis of Parkinson disease (PD) and were scheduled to receive DBS independently of the study. Consenting participants were randomized 1:1 to receive either standard of care or home health postoperative DBS management for 6 months after surgery. Primary caregivers, usually spouses, were also enrolled to assess caregiver strain. INTERVENTIONS: The home health postoperative management was conducted by a home health nurse who chose DBS settings with the aid of the iPad-based Mobile Application for PD DBS system. Prior to the study, the home health nurse had no experience providing DBS care. MAIN OUTCOMES AND MEASURES: The primary outcome was the number of times each patient traveled to the movement disorders clinic during the study period. Secondary outcomes included changes from baseline on the Unified Parkinson's Disease Rating Scale part III. RESULTS: Approximately 75 patients per year were scheduled for DBS. Of the patients who met inclusion criteria over the entire study duration, 45 either declined or were excluded for various reasons. Of the 44 patients enrolled, 19 of 21 randomized patients receiving the standard of care (mean [SD] age, 64.1 [10.0] years; 11 men) and 23 of 23 randomized patients receiving home health who underwent a minimum of 1 postoperative management visit (mean [SD] age, 65.0 [10.9] years; 13 men) were included in analysis. The primary outcome revealed that patients randomized to home health had significantly fewer clinic visits than the patients in the standard of care arm (mean [SD], 0.4 [0.8] visits vs 4.8 [0.4] visits; P < .001). We found no significant differences between the groups in the secondary outcomes measuring the efficacy of DBS. No adverse events occurred in association with the study procedure or devices. CONCLUSIONS AND RELEVANCE: This study provides evidence supporting the safety and feasibility of postoperative home health DBS management. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02474459.
引用
- Duffley G, Lutz BJ, Szabo A, et al. Home Health Management of Parkinson Disease Deep Brain Stimulation: A Randomized Clinical Trial. JAMA Neurol. 2021. PMID: 34180949. doi:10.1001/jamaneurol.2021.1910
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。